Table 3.

Relative levels of research investment, changes in investment over time and associated burden (2010 DALYs) of viral hepatitis

	No. of studies	Total funding	DALY 2004	DALY 2010*	Investment 1997–2004	Investment 2005–2010	Change in investment	Proportional change in investment (%)	Total investment relative to 2004 burden (£ per DALY)	Total investment relative to 2010 burden (£ per DALY)
Hepatitis A	4	£3843 889	−	4 351 000	£883 612	£2960 277	£2076 665	70.2	n/a	£0.88
Hepatitis B	69	£14 728 372	2 067 533	22 602 000	£9829 207	£4899 165	£ −4930 042	−100.6	£7.12	£0.65
Hepatitis C	236	£62 688 106	954 622	12 111 000	£38 124 617	£24 563 489	£ −13 561 128	−55.2	£65.67	£5.18

^*Disability-adjusted life years (DALYs) include burden attributable to acute infection, cirrhosis and hepatocellular carcinoma.